CN106858005A - 一种清烟润喉糖 - Google Patents
一种清烟润喉糖 Download PDFInfo
- Publication number
- CN106858005A CN106858005A CN201510908047.2A CN201510908047A CN106858005A CN 106858005 A CN106858005 A CN 106858005A CN 201510908047 A CN201510908047 A CN 201510908047A CN 106858005 A CN106858005 A CN 106858005A
- Authority
- CN
- China
- Prior art keywords
- parts
- thoat
- soothing drops
- cigarette
- clear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000019504 cigarettes Nutrition 0.000 title claims abstract description 14
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 6
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims abstract description 6
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 6
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 6
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 6
- 244000166124 Eucalyptus globulus Species 0.000 claims abstract description 6
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 6
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 6
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 6
- 235000021282 Sterculia Nutrition 0.000 claims abstract description 6
- 240000001058 Sterculia urens Species 0.000 claims abstract description 6
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 6
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims abstract description 6
- 229960004998 acesulfame potassium Drugs 0.000 claims abstract description 6
- 235000010358 acesulfame potassium Nutrition 0.000 claims abstract description 6
- 239000000619 acesulfame-K Substances 0.000 claims abstract description 6
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 6
- 229940041616 menthol Drugs 0.000 claims abstract description 6
- 229940059107 sterculia Drugs 0.000 claims abstract description 6
- 239000000341 volatile oil Substances 0.000 claims abstract description 6
- -1 hydroxyl isomaltulose Chemical compound 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims abstract description 3
- 244000144725 Amygdalus communis Species 0.000 claims 1
- 235000003893 Prunus dulcis var amara Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 210000000582 semen Anatomy 0.000 abstract description 5
- 230000005586 smoking cessation Effects 0.000 abstract description 5
- 210000004072 lung Anatomy 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 8
- 229960002715 nicotine Drugs 0.000 description 8
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 8
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 7
- 241000208125 Nicotiana Species 0.000 description 6
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 6
- 230000000391 smoking effect Effects 0.000 description 5
- BXNJHAXVSOCGBA-UHFFFAOYSA-N Harmine Chemical compound N1=CC=C2C3=CC=C(OC)C=C3NC2=C1C BXNJHAXVSOCGBA-UHFFFAOYSA-N 0.000 description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
- 208000025569 Tobacco Use disease Diseases 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 229960003638 dopamine Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- RERZNCLIYCABFS-UHFFFAOYSA-N Harmaline hydrochloride Natural products C1CN=C(C)C2=C1C1=CC=C(OC)C=C1N2 RERZNCLIYCABFS-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 235000019506 cigar Nutrition 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 235000019788 craving Nutrition 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- VJHLDRVYTQNASM-UHFFFAOYSA-N harmine Natural products CC1=CN=CC=2NC3=CC(=CC=C3C=21)OC VJHLDRVYTQNASM-UHFFFAOYSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 108010050939 thrombocytin Proteins 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 102000004980 Dopamine D2 Receptors Human genes 0.000 description 1
- 108090001111 Dopamine D2 Receptors Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241001085205 Prenanthella exigua Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229960002069 diamorphine Drugs 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 235000019505 tobacco product Nutrition 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Cosmetics (AREA)
Abstract
一种清烟润喉糖,属于润喉糖技术领域。本发明清烟润喉糖由以下重量份的物质组成:决明子3-40份,胖大海2-30份,罗汉果3-50份,白果3-25份,鱼腥草3-50份,白砂糖300-500份,苦杏仁8-12份,金银花15-35份,异麦芽糖醇200-400份,薄荷脑5-12份,桉油3-8份,安赛蜜0.05-0.5份。本发明戒烟效果显著,随食随取,服用时间短,无毒副作用;戒烟的同时,润喉清肺,其口感和味道好,容易被人们所接受。
Description
技术领域
本发明涉及一种清烟润喉糖,属于润喉糖技术领域。
背景技术
香烟,是烟草制品的一种。制法是把烟草烤干后切丝,然后以纸卷成长约120mm,直径10mm的圆桶形条状。吸食时把其中一端点燃,然后在另一端用口吸咄产生的烟雾。雪茄是以烟草卷成圆桶形条状吸食。香烟跟雪茄的主要分别在于香烟体积较小,烟草经过炼制和切碎。
烟草对大脑的影响:尼古丁通过肺黏膜和口腔黏膜扩散到全身,进入大脑之后,尼古丁能模仿乙酰胆碱这种中枢神经传递物质作用,同许多神经元表面的尼古丁受体结合在一起。尼古丁对中枢神经系统具有刺激作用,在“奖赏回路”内作用尤为明显。它能通过激活相关神经来释放更多的多巴胺。而烟草中所含的的哈尔明和降哈尔明则能通过抑制分解酶的活动,使神经突触内的多巴胺、血清素和去甲肾上腺素保持在高浓度水平。随着多巴胺、血清素和去甲肾上腺素保持的作用得到强化,人的清醒程度就更强、注意力更为集中,从而更能缓解忧虑忍耐饥饿。烟草可导致恶心、眩晕、头痛。耐受性和依赖性:经常吸烟会使大脑中的尼古丁含量始终处于很高水平。神经原受体对尼古丁越来越不敏感,对多巴胺释放的刺激作用也出现减弱,原来的烟量再也不能满足吸烟者的快感,吸烟者由此对尼古丁产生耐受性。当吸烟者停止吸烟数小时(睡眠时间)后,体内尼古丁含量出现下降,神经元受体变得异常敏感,此时乙酰胆碱的活性超出正常水平,使吸烟者变得烦躁,并很想抽烟。这时候如果能够吸一支烟就可以过度刺激神经原受体,并促使多巴胺大量释放。通过这一现象,我们可以明白为什么每天的第一支烟能给“老烟枪”带来莫大的快感,吸烟者也因此陷入烟瘾增强的恶性循环。
烟草中导致烟草依赖的主要物质是尼古丁,其药理学及行为学过程与其他成瘾性物质类似,如海洛因和可卡因等。烟草依赖者一旦停止吸烟,可出现吸烟渴求、焦虑、抑郁、头痛等一系列戒断症状。同时,烟草依赖具有高复发性,其治疗往往需要专业人士及科学方法的辅助。戒烟方法包括戒烟劝诫和药物治疗,规劝效果不明显,复吸的可能性大;药物治疗多采用西药,副作用大。
发明内容
本发明的目的是提供一种清烟润喉糖。
本发明的技术方案包括如下:
本发明清烟润喉糖由以下重量份的物质组成:决明子3-40份,胖大海2-30份,罗汉果3-50份,白果3-25份,鱼腥草3-50份,白砂糖300-500份,苦杏仁8-12份,金银花15-35份,异麦芽糖醇200-400份,薄荷脑5-12份,桉油3-8份,安赛蜜0.05-0.5份。
本发明的有益效果是:
本发明戒烟效果显著,随食随取,服用时间短,无毒副作用;戒烟的同时,润喉清肺,其口感和味道好,容易被人们所接受。
具体实施方式
以下结合技术方案详细叙述本发明的具体实施方式。
实施例1
决明子40份,胖大海30份,罗汉果50份,白果25份,鱼腥草50份,白砂糖500份,苦杏仁12份,金银花35份,异麦芽糖醇400份,薄荷脑12份,桉油8份,安赛蜜0.5份。
实施例2
决明子3份,胖大海2份,罗汉果3份,白果3份,鱼腥草3份,白砂糖300份,苦杏仁8份,金银花15份,异麦芽糖醇200份,薄荷脑5份,桉油3份,安赛蜜0.05份。
实施例3
决明子25份,胖大海20份,罗汉果40份,白果18份,鱼腥草17份,白砂糖400份,苦杏仁10份,金银花25份,异麦芽糖醇300份,薄荷脑7份,桉油6份,安赛蜜0.3份。
Claims (1)
1.一种清烟润喉糖,其特征在于,所述的清烟润喉糖由以下重量份的物质组成:决明子3-40份,胖大海2-30份,罗汉果3-50份,白果3-25份,鱼腥草3-50份,白砂糖300-500份,苦杏仁8-12份,金银花15-35份,异麦芽糖醇200-400份,薄荷脑5-12份,桉油3-8份,安赛蜜0.05-0.5份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510908047.2A CN106858005A (zh) | 2015-12-10 | 2015-12-10 | 一种清烟润喉糖 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510908047.2A CN106858005A (zh) | 2015-12-10 | 2015-12-10 | 一种清烟润喉糖 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106858005A true CN106858005A (zh) | 2017-06-20 |
Family
ID=59237807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510908047.2A Pending CN106858005A (zh) | 2015-12-10 | 2015-12-10 | 一种清烟润喉糖 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106858005A (zh) |
-
2015
- 2015-12-10 CN CN201510908047.2A patent/CN106858005A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Haustein et al. | Tobacco or health?: physiological and social damages caused by tobacco smoking | |
EP2941135B1 (en) | Tobacco substitute | |
EP2265263B1 (de) | Kauzusammensetzung und deren verwendung | |
CN103284319A (zh) | 一种金雀花碱替代尼古丁口腔雾化液及其制备方法 | |
AT501560A1 (de) | Verwendung von kräuterzigaretten | |
JPH11137232A (ja) | ハーブ製品 | |
Elam | Pharmaceutical incursion on cigarette smoking at the birth of the brain disease model of addiction | |
CN103330281A (zh) | 沉香保健香烟 | |
WO2007144081A2 (de) | Raucherentwöhnungs-kombinationswafer | |
CN106858005A (zh) | 一种清烟润喉糖 | |
CN107485673A (zh) | 以中药厚朴刺蒺藜等或其萃取成分为主配方的戒烟溶液 | |
CN106860812A (zh) | 一种戒烟酒 | |
CN106857870A (zh) | 一种戒烟中药豆腐 | |
US10098918B2 (en) | Vaporized medicants and methods of use | |
CN106858702A (zh) | 一种保健香烟 | |
CA3037723A1 (en) | Agents and methods for modulating the sensory impact of tobacco or herbal smoke | |
RU2736490C2 (ru) | Гомеопатическое средство для отвыкания от курения | |
Ray | Effects of nicotine on sperm health and semen quality: a review based on animal studies | |
CN1247720A (zh) | 用作烟草替代品的本草产品及戒断吸烟的方法 | |
US10918684B2 (en) | Vaporized medicants and methods of use | |
US10758582B2 (en) | Vaporized medicants and methods of use | |
JPS63203624A (ja) | 喫煙を止めるための薬剤 | |
Smith | WRIT 159A | |
Hagstrom et al. | Electronic Cigarettes for Smoking Cessation. | |
Milhorn et al. | Cannabis Dependence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170620 |
|
WD01 | Invention patent application deemed withdrawn after publication |